Ratio Therapeutics Revenue and Competitors

Boston, MA USA

Location

#3379

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Ratio Therapeutics's estimated annual revenue is currently $3.8M per year.(i)
  • Ratio Therapeutics's estimated revenue per employee is $69,436
  • Ratio Therapeutics's total funding is $90M.

Employee Data

  • Ratio Therapeutics has 55 Employees.(i)
  • Ratio Therapeutics grew their employee count by 31% last year.

Ratio Therapeutics's People

NameTitleEmail/Phone
1
Chairman, CEOReveal Email/Phone
2
Chief Legal Officer & General CounselReveal Email/Phone
3
CFO and COOReveal Email/Phone
4
Chief Data OfficerReveal Email/Phone
5
Director, President, Chief Scientific OfficerReveal Email/Phone
6
Chief Technology OfficerReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
Head BiologyReveal Email/Phone
9
Head Medical PhysicsReveal Email/Phone
10
Head DiscoveryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M8-20%N/AN/A
#4
$25.7M13820%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M41-2%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M192-7%N/AN/A
Add Company

What Is Ratio Therapeutics?

A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie \theranostics\. The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.

keywords:N/A

$90M

Total Funding

55

Number of Employees

$3.8M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.9M55N/AN/A
#2
$16.3M5510%N/A
#3
$12.1M55-20%N/A
#4
$6.9M5545%N/A
#5
$12.7M55-2%N/A